top of page

 PARTNERS 

EVI recognises the power of collaboration and engages with partners worldwide to harness the best knowledge and expertise from leaders in the field of vaccine research and development (R&D). 

OUR PARTNERS
Global network for worldwide impact

European life-sciences Infrastructure for biological Information (ELIXIR)

United Kingdom

European life-sciences Infrastructure for biological Information (ELIXIR)

​

Eveliqure Biotechnologies GmbH

Austria

Eveliqure Biotechnologies GmbH

​

Expres2ion Biotechnologies APS

Denmark

Expres2ion Biotechnologies APS

​

Flanders Vaccines

Belgium

Flanders Vaccines

​

Fondation Mérieux

France

Fondation Mérieux

​

Fondation mondiale Recherche et Prévention Sida (FMRPS)

Côte d’Ivoire

Fondation mondiale Recherche et Prévention Sida (FMRPS)

​

Fondation pour la Recherche Scientifique (FORS)

Benin

Fondation pour la Recherche Scientifique (FORS)

​

Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico

Italy

Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico

​

Forschungszentrum Jülich GmbH

Germany

Forschungszentrum Jülich GmbH

​

Foundation for Appropriate Technology in Health (FATH)

Switzerland

Foundation for Appropriate Technology in Health (FATH)

​

Fraunhofer Institute for Molecular Biology and Applied Ecology IME

Germany

Fraunhofer Institute for Molecular Biology and Applied Ecology IME

​

French Clinical Research Infrastructure Network (F-CRIN)

France

French Clinical Research Infrastructure Network (F-CRIN)

​

GAC

France

GAC

​

GTP Technology

France

GTP Technology

​

GenIbet Biopharmaceuticals S.A.

Portugal

GenIbet Biopharmaceuticals S.A.

​

Ghent University

Belgium

Ghent University

​

GlaxoSmithKline (GSK)

United Kingdom

GlaxoSmithKline (GSK)

​

GlaxoSmithKline Biologicals SA

Belgium

GlaxoSmithKline Biologicals SA

​

Glaxosmithkline Vaccines Srl

Italy

Glaxosmithkline Vaccines Srl

​

Global Malaria Vaccines GmbH

Germany

Global Malaria Vaccines GmbH

​

Contact us

We'd love to hear from you!

For the latest updates follow EVI on:

  • LinkedIn
  • Twitter
  • YouTube
bottom of page